×




Genzyme's CSR Dilemma: How to Play its HAND Net Present Value (NPV) / MBA Resources

Introduction to Net Present Value (NPV) - What is Net Present Value (NPV) ? How it impacts financial decisions regarding project management?

NPV solution for Genzyme's CSR Dilemma: How to Play its HAND case study


At Oak Spring University, we provide corporate level professional Net Present Value (NPV) case study solution. Genzyme's CSR Dilemma: How to Play its HAND case study is a Harvard Business School (HBR) case study written by Christopher A. Bartlett, Tarun Khanna, Prithwiraj Choudhury. The Genzyme's CSR Dilemma: How to Play its HAND (referred as “Genzyme's Diseases” from here on) case study provides evaluation & decision scenario in field of Global Business. It also touches upon business topics such as - Value proposition, Ethics, Government, Joint ventures, Social responsibility.

The net present value (NPV) of an investment proposal is the present value of the proposal’s net cash flows less the proposal’s initial cash outflow. If a project’s NPV is greater than or equal to zero, the project should be accepted.

NPV = Present Value of Future Cash Flows LESS Project’s Initial Investment






Case Description of Genzyme's CSR Dilemma: How to Play its HAND Case Study


Genzyme, a global biotechnology company, launches a program to develop therapies for neglected diseases, (e.g. malaria, TB), giving away the intellectual property. This case focuses on the decision of which diseases, which partnerships, and which markets should management decide to fund. But the bigger issue is how this program developed under the umbrella role Genzyme's corporate social responsibility fits into its global competitive strategy.


Case Authors : Christopher A. Bartlett, Tarun Khanna, Prithwiraj Choudhury

Topic : Global Business

Related Areas : Ethics, Government, Joint ventures, Social responsibility




Calculating Net Present Value (NPV) at 6% for Genzyme's CSR Dilemma: How to Play its HAND Case Study


Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 6 %
Discounted
Cash Flows
Year 0 (10007051) -10007051 - -
Year 1 3454044 -6553007 3454044 0.9434 3258532
Year 2 3967473 -2585534 7421517 0.89 3531037
Year 3 3947071 1361537 11368588 0.8396 3314037
Year 4 3224897 4586434 14593485 0.7921 2554420
TOTAL 14593485 12658026




The Net Present Value at 6% discount rate is 2650975

In isolation the NPV number doesn't mean much but put in right context then it is one of the best method to evaluate project returns. In this article we will cover -

Different methods of capital budgeting


What is NPV & Formula of NPV,
How it is calculated,
How to use NPV number for project evaluation, and
Scenario Planning given risks and management priorities.




Capital Budgeting Approaches

Methods of Capital Budgeting


There are four types of capital budgeting techniques that are widely used in the corporate world –

1. Profitability Index
2. Net Present Value
3. Internal Rate of Return
4. Payback Period

Apart from the Payback period method which is an additive method, rest of the methods are based on Discounted Cash Flow technique. Even though cash flow can be calculated based on the nature of the project, for the simplicity of the article we are assuming that all the expected cash flows are realized at the end of the year.

Discounted Cash Flow approaches provide a more objective basis for evaluating and selecting investment projects. They take into consideration both –

1. Timing of the expected cash flows – stockholders of Genzyme's Diseases have higher preference for cash returns over 4-5 years rather than 10-15 years given the nature of the volatility in the industry.
2. Magnitude of both incoming and outgoing cash flows – Projects can be capital intensive, time intensive, or both. Genzyme's Diseases shareholders have preference for diversified projects investment rather than prospective high income from a single capital intensive project.






Formula and Steps to Calculate Net Present Value (NPV) of Genzyme's CSR Dilemma: How to Play its HAND

NPV = Net Cash In Flowt1 / (1+r)t1 + Net Cash In Flowt2 / (1+r)t2 + … Net Cash In Flowtn / (1+r)tn
Less Net Cash Out Flowt0 / (1+r)t0

Where t = time period, in this case year 1, year 2 and so on.
r = discount rate or return that could be earned using other safe proposition such as fixed deposit or treasury bond rate. Net Cash In Flow – What the firm will get each year.
Net Cash Out Flow – What the firm needs to invest initially in the project.

Step 1 – Understand the nature of the project and calculate cash flow for each year.
Step 2 – Discount those cash flow based on the discount rate.
Step 3 – Add all the discounted cash flow.
Step 4 – Selection of the project

Why Global Business Managers need to know Financial Tools such as Net Present Value (NPV)?

In our daily workplace we often come across people and colleagues who are just focused on their core competency and targets they have to deliver. For example marketing managers at Genzyme's Diseases often design programs whose objective is to drive brand awareness and customer reach. But how that 30 point increase in brand awareness or 10 point increase in customer touch points will result into shareholders’ value is not specified.

To overcome such scenarios managers at Genzyme's Diseases needs to not only know the financial aspect of project management but also needs to have tools to integrate them into part of the project development and monitoring plan.

Calculating Net Present Value (NPV) at 15%

After working through various assumptions we reached a conclusion that risk is far higher than 6%. In a reasonably stable industry with weak competition - 15% discount rate can be a good benchmark.



Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 15 %
Discounted
Cash Flows
Year 0 (10007051) -10007051 - -
Year 1 3454044 -6553007 3454044 0.8696 3003517
Year 2 3967473 -2585534 7421517 0.7561 2999980
Year 3 3947071 1361537 11368588 0.6575 2595263
Year 4 3224897 4586434 14593485 0.5718 1843845
TOTAL 10442605


The Net NPV after 4 years is 435554

(10442605 - 10007051 )








Calculating Net Present Value (NPV) at 20%


If the risk component is high in the industry then we should go for a higher hurdle rate / discount rate of 20%.

Years              Cash Flow     Net Cash Flow     Cumulative    
Cash Flow
Discount Rate
@ 20 %
Discounted
Cash Flows
Year 0 (10007051) -10007051 - -
Year 1 3454044 -6553007 3454044 0.8333 2878370
Year 2 3967473 -2585534 7421517 0.6944 2755190
Year 3 3947071 1361537 11368588 0.5787 2284185
Year 4 3224897 4586434 14593485 0.4823 1555217
TOTAL 9472961


The Net NPV after 4 years is -534090

At 20% discount rate the NPV is negative (9472961 - 10007051 ) so ideally we can't select the project if macro and micro factors don't allow financial managers of Genzyme's Diseases to discount cash flow at lower discount rates such as 15%.





Acceptance Criteria of a Project based on NPV

Simplest Approach – If the investment project of Genzyme's Diseases has a NPV value higher than Zero then finance managers at Genzyme's Diseases can ACCEPT the project, otherwise they can reject the project. This means that project will deliver higher returns over the period of time than any alternate investment strategy.

In theory if the required rate of return or discount rate is chosen correctly by finance managers at Genzyme's Diseases, then the stock price of the Genzyme's Diseases should change by same amount of the NPV. In real world we know that share price also reflects various other factors that can be related to both macro and micro environment.

In the same vein – accepting the project with zero NPV should result in stagnant share price. Finance managers use discount rates as a measure of risk components in the project execution process.

Sensitivity Analysis

Project selection is often a far more complex decision than just choosing it based on the NPV number. Finance managers at Genzyme's Diseases should conduct a sensitivity analysis to better understand not only the inherent risk of the projects but also how those risks can be either factored in or mitigated during the project execution. Sensitivity analysis helps in –

What will be a multi year spillover effect of various taxation regulations.

What are the key aspects of the projects that need to be monitored, refined, and retuned for continuous delivery of projected cash flows.

Understanding of risks involved in the project.

What can impact the cash flow of the project.

What are the uncertainties surrounding the project Initial Cash Outlay (ICO’s). ICO’s often have several different components such as land, machinery, building, and other equipment.

Some of the assumptions while using the Discounted Cash Flow Methods –

Projects are assumed to be Mutually Exclusive – This is seldom the came in modern day giant organizations where projects are often inter-related and rejecting a project solely based on NPV can result in sunk cost from a related project.

Independent projects have independent cash flows – As explained in the marketing project – though the project may look independent but in reality it is not as the brand awareness project can be closely associated with the spending on sales promotions and product specific advertising.






Negotiation Strategy of Genzyme's CSR Dilemma: How to Play its HAND

References & Further Readings

Christopher A. Bartlett, Tarun Khanna, Prithwiraj Choudhury (2018), "Genzyme's CSR Dilemma: How to Play its HAND Harvard Business Review Case Study. Published by HBR Publications.


Fidelix SWOT Analysis / TOWS Matrix

Technology , Semiconductors


Guizhou Taiyong Changzheng A SWOT Analysis / TOWS Matrix

Technology , Electronic Instr. & Controls


Lydall SWOT Analysis / TOWS Matrix

Capital Goods , Misc. Capital Goods


ETV Michigan MIT SWOT Analysis / TOWS Matrix

Financial , Misc. Financial Services


Manulife SWOT Analysis / TOWS Matrix

Financial , Insurance (Life)


KMH Hi Tech SWOT Analysis / TOWS Matrix

Technology , Semiconductors


EST Tools SWOT Analysis / TOWS Matrix

Capital Goods , Misc. Capital Goods


Banca Finnat SWOT Analysis / TOWS Matrix

Financial , Investment Services


MGC Pharma SWOT Analysis / TOWS Matrix

Healthcare , Biotechnology & Drugs


Cape Industries Ltd SWOT Analysis / TOWS Matrix

Capital Goods , Misc. Capital Goods